Peptide Comparison
Pal-GHK vs Syn-Ake
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Pal-GHK and Syn-Ake share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Pal-GHK has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Pal-GHK's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Pal-GHK | Syn-Ake | |
|---|---|---|
| Class | Cosmetic lipopeptide (collagen) | Cosmetic peptide (snake-venom inspired) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Palmitoyl-modified GHK for enhanced penetration; copper-independent collagen signaling | Waglerin-1 mimic; antagonizes nicotinic ACh receptor at muscle |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 1-3% | Topical 4% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 19 indexed | 5 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Pal-GHK or Syn-Ake?
Pal-GHK and Syn-Ake share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Pal-GHK has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Pal-GHK's evidence base is currently denser.
What is the difference between Pal-GHK and Syn-Ake?
Pal-GHK is classed as Cosmetic lipopeptide (collagen); Syn-Ake is classed as Cosmetic peptide (snake-venom inspired). Reported mechanism: Pal-GHK, Palmitoyl-modified GHK for enhanced penetration; copper-independent collagen signaling; Syn-Ake, Waglerin-1 mimic; antagonizes nicotinic ACh receptor at muscle. Reported half-life: Pal-GHK, Topical; Syn-Ake, Topical. Routes in published studies: Pal-GHK, Topical; Syn-Ake, Topical.
Which has stronger evidence, Pal-GHK or Syn-Ake?
Pal-GHK and Syn-Ake sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Pal-GHK is graded Cosmetic Clinical Studies, with 5 cited sources on its reference page and 19 indexed studies. Syn-Ake is graded Cosmetic Clinical Studies, with 3 cited sources on its reference page and 5 indexed studies.
Which is more accessible, Pal-GHK or Syn-Ake?
Neither Pal-GHK nor Syn-Ake is an FDA-approved drug. Catalog status: Pal-GHK, Cosmetic; Syn-Ake, Cosmetic.
Are Pal-GHK and Syn-Ake ever combined?
Pal-GHK and Syn-Ake appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…